Skip to content

Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals

Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02080975
Acronym
IN-CONTACT
Enrollment
20
Registered
2014-03-07
Start date
2014-03-31
Completion date
2015-12-31
Last updated
2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Flutter, Cardiac Arrhythmias, Cardiac Catheter Ablation

Brief summary

Successful radio frequency (RF) cardiac catheter ablation requires the creation of lesions by delivering energy while maintaining adequate catheter contact with the endocardium. Unfortunately, it is difficult to identify contact intraoperatively as a typical RF ablation catheter lacks clear indications of contact. We propose to use the Boston Scientific IntellaTip MiFi catheter to explore whether characteristics of the electrograms produced by the mini-electrodes on the ablation tip could help confirm tissue contact. Using an ultrasound catheter to define instances of clear contact and non-contact, we will determine whether the micro-electrodes produce sufficient information to confirm catheter contact. We propose that the MiFi catheter produces sufficient signal characteristics that can be used as an effective surrogate for adequate tissue contact.

Interventions

OTHERData Collection During Atrial Flutter Ablation

All enrolled patients are clinically indicated for an atrial flutter ablation. The patients who consent for this study will have additional electrocardiograms taken during their procedure for future review, as well as ultrasound images form inside their heart. This will lengthen the ablation by approximately 10 minutes, but is not a separate procedure.

Sponsors

Boston Scientific Corporation
CollaboratorINDUSTRY
David B. De Lurgio
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject has a diagnosis of typical atrial flutter * Subject is clinically indicated for right sided atrial flutter ablation * Patient is willing and able to understand and sign the informed consent document * Patient is over 18 years of age * Patient is willing and able to comply with the study protocol

Exclusion criteria

* Patient has one of the following cardiac comorbidities: hypertrophic cardiomyopathy, structural heart disease, congestive heart failure * Patient has history of the following arrhythmias: ventricular tachycardia, ventricular fibrillation, Wolff-Parkinson-White syndrome * Patient has a contraindication to right atrium ablation, including but not limited to: right atrial thrombus, active systemic infection, or a coagulopathy.

Design outcomes

Primary

MeasureTime frameDescription
Correlation between catheter contact and micro electrode signalsDuring ProcedureThe known contact state of the ablation catheter will be compared in a blinded fashion to the signals from the microelectrodes to determine if a relationship exits.

Secondary

MeasureTime frame
Document the electrogram signatures that help demonstrate catheter tip contactDuring Procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026